Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies. (Record no. 30436870)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01369 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518074704.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202102s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1573-2576 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s10753-019-01157-0 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bergantini, L |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210208 |
| 245 00 - TITLE STATEMENT | |
| Title | Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Inflammation |
| Date of publication, distribution, etc. | Apr 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 393-400 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Review |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Asthmatic Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Asthma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Daclizumab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Delivery Systems |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | T-Lymphocytes, Regulatory |
| General subdivision | immunology |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cameli, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | d'Alessandro, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vietri, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Perruzza, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pieroni, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lanzarone, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Refini, R M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fossi, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bargagli, E |
| 773 0# - HOST ITEM ENTRY | |
| Title | Inflammation |
| Related parts | vol. 43 |
| -- | no. 2 |
| -- | p. 393-400 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10753-019-01157-0">https://doi.org/10.1007/s10753-019-01157-0</a> |
| Public note | Available from publisher's website |
No items available.